Search
for

    Sort by

    Research 301–330 of 1000+

    1. Clinical Outcomes of Ritlecitinib in Treatment-Refractory Alopecia Areata: A Single-Center Real-World Study Skin Appendage Disorders · 2026
    2. Therapeutic Role of Pracchanna and Lepana in Indralupta (Alopecia Areata): A Case Study Journal of Indian System of Medicine · 2026
    3. A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics Frontiers in Medicine · 2026
    4. AYURVEDIC MANAGEMENT OF INDRALUPTA(ALOPECIA AREATA): A CASE REPORT International journal of applied ayurved research. · 2026
    5. Comparative Effectiveness and Safety of Baricitinib and Ritlecitinib in Severe Alopecia Areata: A Real-World Monocentric Retrospective Study Dermatology and Therapy · 2026
    6. Long-term Efficacy and Safety of Upadacitinib in the Treatment of Alopecia Areata: A Retrospective Study Journal of the American Academy of Dermatology · 2026
    7. Management of Alopecia Areata through Unani Medicine Hippocratic Journal of Unani Medicine · 2026
    8. Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study Acta Dermato Venereologica · 2026
    9. COMPARISON OF CLINICAL EFFICACY OF TOFACITINIB VERSUS METHOTREXATE IN SEVERE ALOPECIA AREATA, ALOPECIA TOTALIS, AND ALOPECIA UNIVERSALIS: A RANDOMIZED CONTROLLED TRIAL Khyber Journal Of Medical Sciences · 2026
    10. What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered? Open MIND · 2026
    11. What is the appropriate indication for baricitinib in patients with alopecia areata? What prior options can be considered? Zenodo (CERN European Organization for Nuclear Research) · 2026
    12. A Pilot Randomized Controlled Trial Comparing the Efficacy and Safety of Oral Tofacitinib Versus Methotrexate In Moderate-to-Severe Alopecia Areata Indian Dermatology Online Journal · 2026
    13. High-Dose Baricitinib for Severe Alopecia Areata with Suboptimal Response to Conventional Therapy: A Real-World Assessment Clinical Cosmetic and Investigational Dermatology · 2026
    14. BH21 Efficacy and safety of oral Janus kinase inhibitors in the treatment of alopecia areata: a systematic review and meta-analysis British Journal of Dermatology · 2026
    15. P151 A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: patient-reported outcome measures British Journal of Dermatology · 2026
    16. A Case Report on Siddha Medicines Parangipattai Chooranam Tablet (Internal), Palagarai Parpa Tablet (Internal) and Muthiyar Koondhal Ennai (External) in the Management of Puzhuvettu International Journal of Pharmaceutical Sciences Review and Research · 2026
    17. P165 Real-world experience of ritlecitinib for the treatment of alopecia areata from an alopecia clinic in a large tertiary dermatology centre British Journal of Dermatology · 2026
    18. P146 A multicentre retrospective study evaluating the real-world efficacy and safety of ritlecitinib in the treatment of alopecia areata British Journal of Dermatology · 2026
    19. BH31 Ritlecitinib for severe alopecia areata: does regional prescribing match national guidance? British Journal of Dermatology · 2026
    20. BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata British Journal of Dermatology · 2026
    21. Alopecia Areata With an FFA ‐Like Phenotype: Clinicopathologic Features and Treatment Outcomes in a Prospective Cohort International Journal of Dermatology · 2026
    22. Rapid Hair Regrowth in Localized Alopecia Areata Following Low-Dose Intralesional Corticosteroid Journal of Asia Pacific Aesthetic Sciences · 2026
    23. Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital Indian Journal of Dermatology · 2026
    24. Case Report: Dupilumab induced sustained complete remission in a child with severe alopecia areata and markedly elevated IgE SHILAP Revista de lepidopterología · 2026
    25. Bridging psychoneuroimmunology and homeopathy: Modulating the cellular and emotional cascades in refractory alopecia International Journal of Homoeopathic Sciences · 2026
    26. Limitations of Treatment-Induced Alopecia Grading Instruments in Evaluating Therapeutic Response Academic Dermatology · 2026
    27. Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study Clinical and Translational Science · 2026
    28. How Long to Treat to Achieve Desired Treatment Outcomes with Baricitinib 4 mg in Severe Alopecia Areata: Evidence-based Approach Dermatology and Therapy · 2026
    29. Efficacy and predictive markers of response to tofacitinib and baricitinib therapy in alopecia areata: A 52-week comparative cohort study Meditsinskiy sovet = Medical Council · 2026
    30. AYURVEDIC MANAGEMENT OF ALOPECIA AREATA USING VIDDHAKARMA AS A PARA-SURGICAL PROCEDURE: A CASE STUDY ˜The œBioscan. · 2026